raloxifene hydrochloride has been researched along with omacor in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demers, LM; DuBrock, C; El-Bayoumy, K; Hamilton, C; Hartman, TJ; Liao, J; Manni, A; Prokopczyk, B; Richie, JP; Signori, C | 1 |
| Aliaga, C; Calcagnotto, A; Demers, LM; DuBrock, C; El-Bayoumy, K; Hamilton, C; Hartman, TJ; Liao, J; Manni, A; McGinley, J; Prokopczyk, B; Richie, JP; Sandhu, N; Schetter, SE; Signori, C; Thompson, HJ; Trushin, N | 1 |
| Aliaga, C; Calcagnotto, A; El-Bayoumy, K; Manni, A; Richie, JP; Schetter, SE; Trushin, N | 1 |
3 trial(s) available for raloxifene hydrochloride and omacor
| Article | Year |
|---|---|
Administration of omega-3 fatty acids and Raloxifene to women at high risk of breast cancer: interim feasibility and biomarkers analysis from a clinical trial.
Topics: Adult; Aged; Biomarkers; Breast Neoplasms; C-Reactive Protein; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Drug Combinations; Eicosapentaenoic Acid; Endpoint Determination; Estrogen Antagonists; Fatty Acids, Omega-3; Feasibility Studies; Feeding Behavior; Female; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Linear Models; Lipid Peroxidation; Middle Aged; Motor Activity; Oxidative Stress; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Signal Transduction | 2012 |
Influence of Obesity on Breast Density Reduction by Omega-3 Fatty Acids: Evidence from a Randomized Clinical Trial.
Topics: Adult; Aged; Body Mass Index; Breast; Breast Density; Breast Neoplasms; Docosahexaenoic Acids; Drug Combinations; Drug Therapy, Combination; Eicosapentaenoic Acid; Estrogen Antagonists; Female; Follow-Up Studies; Humans; Mammography; Middle Aged; Obesity; Raloxifene Hydrochloride; Tamoxifen | 2016 |
Stearoyl-CoA desaturase-1, a novel target of omega-3 fatty acids for reducing breast cancer risk in obese postmenopausal women.
Topics: Adult; Aged; Biomarkers; Body Mass Index; Breast Density; Breast Neoplasms; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Drug Combinations; Eicosapentaenoic Acid; Estrogen Receptor Modulators; Fatty Acids; Fatty Acids, Monounsaturated; Fatty Acids, Omega-3; Female; Follow-Up Studies; Humans; Middle Aged; Obesity; Oleic Acid; Palmitic Acid; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Stearoyl-CoA Desaturase | 2017 |